INTRACT PHARMA LTD has a total of 13 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in United Kingdom and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are TAIWAN LIPOSOME CO LTD, TIZIANA LIFE SCIENCES PLC and NOVINTETHICAL PHARMA SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Yadav Vipul | 3 |
#2 | Basit Abdul | 2 |
#3 | Tomioka Motoyasu | 1 |
#4 | Wada Yasufumi | 1 |
#5 | Basit Abdul Waseh | 1 |
#6 | Kawata Satofumi | 1 |
Publication | Filing date | Title |
---|---|---|
GB202017863D0 | Novel compositions | |
GB201906906D0 | Novel compositions | |
GB201906917D0 | Novel compositions | |
GB201906171D0 | Di-peptides | |
GB201905940D0 | 5-aminolevulinic acid for the local treatment of inflammatory bowel disease | |
WO2019097251A1 | Novel compositions | |
GB201816543D0 | Novel compounds | |
GB201807971D0 | Novel compositions | |
GB201807972D0 | Novel compositions | |
GB201719083D0 | Novel compositions | |
GB201719085D0 | Novel Compositions |